AimThe aim of this study was to develop systems containing dehydroepiandrosterone (DHEA), in the form of an inclusion complex with α-cyclodestrin (c-DHEA), which are able to change the release profile of the hormone according to time and excipient composition.MethodTwenty-five formulations were prepared containing DHEA (prasterone) in the chemical form of an inclusion complex with α-cyclodextrin (57.3% w/w). The drug was mixed with three different excipient systems: the first ‘fast’ one was a mixture of two disintegrants (microcrystalline cellulose and sodium carboxymethyl starch at prefixed 4.15 weight ratio); the second ‘gelling’ excipient contained two gel-forming agents (high viscosity hydroxypropyl methylcellulose and cross-linked polyvinyl pyrrolidone) at three weight ratios: 0.31, 1.00, and 2.45; and the third type of ‘binary’ mixture was prepared by combining ‘fast’ and ‘gelling’ systems at three weight ratios: 1:2, 1:1, and 2:1. Tablets were prepared by direct compression or after wet granulation of these formulations.Results’Fast’ tablets induced a rapid release of the drug while ‘gelling’ tablets were found to modify the release, according to composition. A profile, characterized by an initial phase of rapid drug release, followed by a period of slower release is achieved with series 1:1 tablets. Series 1:2 tablets provide linear release of the drug; while an undifferentiated profile was found for series 2:1 tablets.ConclusionDifferent release mechanisms and the control of drug release were obtained by using DHEA in its inclusion complex and varying the weight ratios of the excipients.
Read full abstract